| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 101 | 2026 | 626 | 19.280 |
Why?
|
| Aortic Aneurysm, Abdominal | 69 | 2026 | 223 | 18.680 |
Why?
|
| Blood Vessel Prosthesis Implantation | 88 | 2026 | 276 | 17.570 |
Why?
|
| Vascular Surgical Procedures | 58 | 2025 | 240 | 9.330 |
Why?
|
| Blood Vessel Prosthesis | 48 | 2026 | 214 | 7.200 |
Why?
|
| Aortic Aneurysm, Thoracic | 29 | 2026 | 108 | 6.940 |
Why?
|
| Peripheral Arterial Disease | 35 | 2026 | 165 | 6.190 |
Why?
|
| Ischemia | 36 | 2026 | 203 | 5.930 |
Why?
|
| Lower Extremity | 37 | 2025 | 160 | 4.500 |
Why?
|
| Treatment Outcome | 137 | 2026 | 5765 | 4.040 |
Why?
|
| Quality Indicators, Health Care | 15 | 2026 | 345 | 3.950 |
Why?
|
| Time Factors | 111 | 2026 | 3748 | 3.880 |
Why?
|
| Risk Factors | 125 | 2026 | 5392 | 3.400 |
Why?
|
| Aortic Aneurysm | 9 | 2026 | 81 | 3.390 |
Why?
|
| Vascular Grafting | 12 | 2026 | 37 | 3.370 |
Why?
|
| Stents | 30 | 2025 | 494 | 3.360 |
Why?
|
| Surgeons | 15 | 2026 | 189 | 2.840 |
Why?
|
| Retrospective Studies | 99 | 2026 | 6818 | 2.820 |
Why?
|
| Risk Assessment | 70 | 2026 | 2090 | 2.710 |
Why?
|
| Postoperative Complications | 48 | 2026 | 1313 | 2.700 |
Why?
|
| Aged, 80 and over | 92 | 2026 | 5590 | 2.600 |
Why?
|
| Aged | 140 | 2026 | 14882 | 2.540 |
Why?
|
| Carotid Stenosis | 10 | 2021 | 99 | 2.500 |
Why?
|
| Prosthesis Design | 30 | 2026 | 218 | 2.470 |
Why?
|
| Hospitals, High-Volume | 5 | 2026 | 36 | 2.370 |
Why?
|
| Saphenous Vein | 14 | 2025 | 51 | 2.260 |
Why?
|
| Computed Tomography Angiography | 10 | 2021 | 140 | 2.220 |
Why?
|
| Humans | 218 | 2026 | 64768 | 2.210 |
Why?
|
| Databases, Factual | 32 | 2026 | 880 | 2.060 |
Why?
|
| Ultrasonography, Doppler, Duplex | 10 | 2021 | 47 | 2.060 |
Why?
|
| Male | 150 | 2026 | 30840 | 2.010 |
Why?
|
| Specialties, Surgical | 6 | 2023 | 46 | 2.000 |
Why?
|
| Aortic Rupture | 13 | 2026 | 47 | 1.980 |
Why?
|
| Female | 151 | 2026 | 33804 | 1.890 |
Why?
|
| Limb Salvage | 26 | 2025 | 65 | 1.870 |
Why?
|
| Endarterectomy, Carotid | 20 | 2024 | 79 | 1.830 |
Why?
|
| Aneurysm | 5 | 2023 | 58 | 1.770 |
Why?
|
| Reoperation | 31 | 2026 | 300 | 1.700 |
Why?
|
| Aorta, Abdominal | 8 | 2023 | 56 | 1.670 |
Why?
|
| Vascular Patency | 26 | 2024 | 134 | 1.630 |
Why?
|
| United States | 62 | 2026 | 8052 | 1.620 |
Why?
|
| Peripheral Vascular Diseases | 13 | 2023 | 45 | 1.510 |
Why?
|
| Arteriovenous Shunt, Surgical | 10 | 2020 | 43 | 1.500 |
Why?
|
| Aortic Diseases | 5 | 2023 | 65 | 1.490 |
Why?
|
| Middle Aged | 87 | 2026 | 18156 | 1.440 |
Why?
|
| Education, Medical, Graduate | 9 | 2021 | 348 | 1.430 |
Why?
|
| Endoleak | 14 | 2026 | 39 | 1.400 |
Why?
|
| Physician's Role | 6 | 2020 | 122 | 1.380 |
Why?
|
| Clinical Competence | 12 | 2026 | 727 | 1.360 |
Why?
|
| Practice Patterns, Physicians' | 13 | 2025 | 705 | 1.360 |
Why?
|
| Hospital Mortality | 19 | 2025 | 873 | 1.350 |
Why?
|
| Internship and Residency | 9 | 2021 | 805 | 1.350 |
Why?
|
| Prospective Studies | 34 | 2025 | 3297 | 1.350 |
Why?
|
| Graft Occlusion, Vascular | 16 | 2021 | 60 | 1.290 |
Why?
|
| Hospitals, Low-Volume | 3 | 2026 | 20 | 1.270 |
Why?
|
| Kaplan-Meier Estimate | 30 | 2024 | 413 | 1.240 |
Why?
|
| Aortography | 7 | 2022 | 58 | 1.200 |
Why?
|
| Leg | 6 | 2013 | 87 | 1.140 |
Why?
|
| Fee-for-Service Plans | 3 | 2020 | 69 | 1.120 |
Why?
|
| Clinical Coding | 3 | 2018 | 46 | 1.100 |
Why?
|
| Decision Support Techniques | 11 | 2019 | 193 | 1.080 |
Why?
|
| Iliac Aneurysm | 3 | 2023 | 10 | 1.050 |
Why?
|
| Predictive Value of Tests | 21 | 2024 | 1102 | 1.040 |
Why?
|
| Registries | 31 | 2025 | 906 | 1.020 |
Why?
|
| Renal Dialysis | 10 | 2016 | 191 | 1.020 |
Why?
|
| Practice Guidelines as Topic | 5 | 2025 | 734 | 1.020 |
Why?
|
| Spinal Cord Ischemia | 5 | 2025 | 15 | 0.950 |
Why?
|
| Angioplasty | 7 | 2022 | 53 | 0.890 |
Why?
|
| Aorta, Thoracic | 3 | 2026 | 80 | 0.880 |
Why?
|
| Carotid Artery Diseases | 5 | 2018 | 61 | 0.860 |
Why?
|
| Brachial Artery | 5 | 2016 | 28 | 0.850 |
Why?
|
| Aneurysm, Infected | 2 | 2015 | 13 | 0.850 |
Why?
|
| Aneurysm, False | 1 | 2023 | 47 | 0.760 |
Why?
|
| New England | 29 | 2016 | 269 | 0.740 |
Why?
|
| Natural Language Processing | 1 | 2022 | 52 | 0.720 |
Why?
|
| Reproducibility of Results | 12 | 2024 | 1686 | 0.720 |
Why?
|
| Benchmarking | 7 | 2026 | 137 | 0.710 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 142 | 0.710 |
Why?
|
| Fiber Optic Technology | 1 | 2021 | 22 | 0.710 |
Why?
|
| Hospital Costs | 5 | 2020 | 126 | 0.710 |
Why?
|
| Workload | 6 | 2021 | 130 | 0.690 |
Why?
|
| Chi-Square Distribution | 26 | 2017 | 412 | 0.660 |
Why?
|
| Elective Surgical Procedures | 8 | 2025 | 119 | 0.660 |
Why?
|
| Health Services Needs and Demand | 3 | 2020 | 219 | 0.660 |
Why?
|
| Relative Value Scales | 2 | 2020 | 14 | 0.650 |
Why?
|
| Carotid Artery, Internal | 2 | 2018 | 68 | 0.640 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 205 | 0.640 |
Why?
|
| Patient Care Team | 4 | 2020 | 335 | 0.640 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 219 | 0.640 |
Why?
|
| Medicare | 6 | 2025 | 619 | 0.630 |
Why?
|
| Intermittent Claudication | 6 | 2018 | 53 | 0.630 |
Why?
|
| Documentation | 2 | 2018 | 133 | 0.620 |
Why?
|
| Data Accuracy | 2 | 2018 | 31 | 0.620 |
Why?
|
| Hospitals | 4 | 2014 | 385 | 0.610 |
Why?
|
| Celiac Artery | 1 | 2019 | 13 | 0.610 |
Why?
|
| Quality Improvement | 6 | 2018 | 459 | 0.610 |
Why?
|
| Leadership | 3 | 2020 | 211 | 0.590 |
Why?
|
| Betacoronavirus | 2 | 2020 | 181 | 0.580 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2018 | 6 | 0.580 |
Why?
|
| Diagnosis-Related Groups | 2 | 2018 | 86 | 0.570 |
Why?
|
| Chronic Disease | 10 | 2026 | 741 | 0.560 |
Why?
|
| Forms and Records Control | 1 | 2018 | 14 | 0.560 |
Why?
|
| Drainage | 3 | 2025 | 152 | 0.550 |
Why?
|
| Comorbidity | 15 | 2024 | 1097 | 0.550 |
Why?
|
| Stroke | 11 | 2022 | 1206 | 0.550 |
Why?
|
| Proportional Hazards Models | 20 | 2017 | 735 | 0.550 |
Why?
|
| Medical Records | 1 | 2018 | 139 | 0.540 |
Why?
|
| Models, Cardiovascular | 3 | 2017 | 83 | 0.540 |
Why?
|
| Terminology as Topic | 2 | 2016 | 144 | 0.540 |
Why?
|
| Needs Assessment | 2 | 2018 | 201 | 0.530 |
Why?
|
| Societies, Medical | 7 | 2020 | 400 | 0.530 |
Why?
|
| Current Procedural Terminology | 2 | 2020 | 18 | 0.520 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 136 | 0.520 |
Why?
|
| Contracts | 1 | 2017 | 6 | 0.520 |
Why?
|
| Negotiating | 1 | 2017 | 16 | 0.510 |
Why?
|
| Subclavian Artery | 2 | 2015 | 26 | 0.510 |
Why?
|
| Device Approval | 1 | 2017 | 13 | 0.510 |
Why?
|
| Odds Ratio | 19 | 2017 | 754 | 0.510 |
Why?
|
| Iliac Artery | 4 | 2024 | 43 | 0.510 |
Why?
|
| Severity of Illness Index | 12 | 2024 | 1553 | 0.510 |
Why?
|
| Multivariate Analysis | 19 | 2017 | 927 | 0.500 |
Why?
|
| Vascular Diseases | 4 | 2022 | 81 | 0.500 |
Why?
|
| Computer Simulation | 4 | 2019 | 482 | 0.500 |
Why?
|
| Massachusetts | 7 | 2020 | 2130 | 0.500 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 90 | 0.490 |
Why?
|
| Myocardial Ischemia | 2 | 2014 | 117 | 0.490 |
Why?
|
| Critical Care | 1 | 2020 | 400 | 0.480 |
Why?
|
| Popliteal Artery | 2 | 2024 | 24 | 0.470 |
Why?
|
| Survival Rate | 10 | 2021 | 843 | 0.470 |
Why?
|
| Patient Selection | 16 | 2019 | 483 | 0.470 |
Why?
|
| Patient Compliance | 2 | 2016 | 364 | 0.470 |
Why?
|
| Guideline Adherence | 2 | 2015 | 302 | 0.460 |
Why?
|
| Disease-Free Survival | 8 | 2018 | 242 | 0.460 |
Why?
|
| Critical Illness | 10 | 2025 | 328 | 0.440 |
Why?
|
| Femoral Artery | 2 | 2024 | 104 | 0.440 |
Why?
|
| Wound Infection | 3 | 2024 | 29 | 0.440 |
Why?
|
| Personnel Selection | 3 | 2020 | 57 | 0.440 |
Why?
|
| Practice Management, Medical | 1 | 2015 | 20 | 0.440 |
Why?
|
| Carotid Arteries | 2 | 2015 | 63 | 0.440 |
Why?
|
| Follow-Up Studies | 13 | 2020 | 2473 | 0.440 |
Why?
|
| Diagnostic Imaging | 2 | 2014 | 272 | 0.430 |
Why?
|
| Logistic Models | 16 | 2017 | 1267 | 0.430 |
Why?
|
| Smoking Prevention | 4 | 2017 | 163 | 0.430 |
Why?
|
| Arm | 4 | 2008 | 45 | 0.420 |
Why?
|
| Myocardial Infarction | 12 | 2024 | 918 | 0.410 |
Why?
|
| Length of Stay | 8 | 2026 | 824 | 0.410 |
Why?
|
| Medical Audit | 1 | 2014 | 66 | 0.410 |
Why?
|
| Wound Healing | 4 | 2024 | 193 | 0.400 |
Why?
|
| Turner Syndrome | 1 | 2013 | 9 | 0.400 |
Why?
|
| Program Evaluation | 6 | 2018 | 488 | 0.390 |
Why?
|
| Brachiocephalic Veins | 2 | 2010 | 5 | 0.390 |
Why?
|
| Tuberculosis, Cardiovascular | 1 | 2012 | 2 | 0.380 |
Why?
|
| Cryopreservation | 1 | 2012 | 30 | 0.370 |
Why?
|
| Mycobacterium bovis | 1 | 2012 | 29 | 0.370 |
Why?
|
| BCG Vaccine | 1 | 2012 | 55 | 0.370 |
Why?
|
| Bioprosthesis | 1 | 2012 | 38 | 0.360 |
Why?
|
| Regional Blood Flow | 5 | 2019 | 116 | 0.360 |
Why?
|
| Radiography, Interventional | 2 | 2009 | 82 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 767 | 0.350 |
Why?
|
| Self Report | 1 | 2014 | 391 | 0.350 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2012 | 108 | 0.350 |
Why?
|
| Cardiology | 3 | 2018 | 169 | 0.340 |
Why?
|
| Treatment Failure | 6 | 2025 | 206 | 0.340 |
Why?
|
| Cost-Benefit Analysis | 4 | 2020 | 316 | 0.330 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 214 | 0.330 |
Why?
|
| Renal Artery | 2 | 2021 | 36 | 0.330 |
Why?
|
| Healthcare Disparities | 5 | 2021 | 407 | 0.330 |
Why?
|
| Risk Reduction Behavior | 3 | 2017 | 121 | 0.330 |
Why?
|
| Smoking Cessation | 4 | 2017 | 551 | 0.320 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2024 | 233 | 0.320 |
Why?
|
| Catheterization, Central Venous | 3 | 2020 | 84 | 0.320 |
Why?
|
| Aorta | 2 | 2023 | 108 | 0.310 |
Why?
|
| Advisory Committees | 4 | 2020 | 111 | 0.310 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 178 | 0.300 |
Why?
|
| Infection Control | 2 | 2020 | 104 | 0.300 |
Why?
|
| North America | 3 | 2023 | 113 | 0.300 |
Why?
|
| Patient Readmission | 3 | 2024 | 446 | 0.290 |
Why?
|
| Kidney Diseases | 1 | 2010 | 177 | 0.290 |
Why?
|
| Fellowships and Scholarships | 1 | 2009 | 105 | 0.280 |
Why?
|
| Upper Extremity | 4 | 2022 | 54 | 0.280 |
Why?
|
| Arteriosclerosis | 1 | 2008 | 32 | 0.280 |
Why?
|
| Prosthesis-Related Infections | 1 | 2008 | 34 | 0.270 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 141 | 0.270 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 54 | 0.270 |
Why?
|
| Feasibility Studies | 4 | 2024 | 581 | 0.270 |
Why?
|
| Device Removal | 1 | 2008 | 64 | 0.270 |
Why?
|
| American Heart Association | 3 | 2017 | 128 | 0.270 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 642 | 0.260 |
Why?
|
| Arteries | 3 | 2023 | 81 | 0.260 |
Why?
|
| Catheters | 3 | 2022 | 76 | 0.260 |
Why?
|
| Extremities | 1 | 2007 | 63 | 0.260 |
Why?
|
| Thrombosis | 3 | 2016 | 202 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2020 | 260 | 0.250 |
Why?
|
| Databases as Topic | 4 | 2010 | 49 | 0.250 |
Why?
|
| Disease Management | 3 | 2017 | 233 | 0.250 |
Why?
|
| Patient Discharge | 4 | 2024 | 518 | 0.250 |
Why?
|
| Photoplethysmography | 1 | 2006 | 37 | 0.250 |
Why?
|
| Health Care Costs | 3 | 2020 | 222 | 0.240 |
Why?
|
| Hand | 1 | 2006 | 76 | 0.240 |
Why?
|
| Adult | 21 | 2020 | 17251 | 0.240 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2006 | 99 | 0.240 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 123 | 0.230 |
Why?
|
| Vascular Remodeling | 1 | 2025 | 23 | 0.230 |
Why?
|
| Failure to Rescue, Health Care | 1 | 2025 | 5 | 0.230 |
Why?
|
| Salvage Therapy | 1 | 2025 | 75 | 0.230 |
Why?
|
| Counseling | 3 | 2017 | 375 | 0.220 |
Why?
|
| Retreatment | 3 | 2021 | 43 | 0.220 |
Why?
|
| Technology | 2 | 2022 | 53 | 0.220 |
Why?
|
| Radiation Exposure | 1 | 2025 | 24 | 0.220 |
Why?
|
| Clinical Decision-Making | 3 | 2021 | 168 | 0.220 |
Why?
|
| Incidence | 9 | 2025 | 1410 | 0.220 |
Why?
|
| Patients | 2 | 2016 | 114 | 0.220 |
Why?
|
| Computer-Assisted Instruction | 2 | 2017 | 79 | 0.220 |
Why?
|
| Prognosis | 7 | 2021 | 1772 | 0.210 |
Why?
|
| Blood Pressure | 1 | 2006 | 521 | 0.210 |
Why?
|
| Transplantation, Autologous | 3 | 2009 | 128 | 0.210 |
Why?
|
| Certification | 2 | 2018 | 58 | 0.200 |
Why?
|
| Intraoperative Complications | 2 | 2021 | 88 | 0.200 |
Why?
|
| Jugular Veins | 2 | 2000 | 28 | 0.200 |
Why?
|
| Teaching | 2 | 2015 | 163 | 0.190 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 554 | 0.190 |
Why?
|
| Tertiary Care Centers | 2 | 2021 | 110 | 0.190 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 625 | 0.190 |
Why?
|
| Health Care Sector | 2 | 2015 | 20 | 0.190 |
Why?
|
| Spinal Cord Injuries | 1 | 2023 | 54 | 0.190 |
Why?
|
| Air | 1 | 2002 | 16 | 0.190 |
Why?
|
| Breast Implants | 1 | 2002 | 14 | 0.180 |
Why?
|
| Postoperative Hemorrhage | 3 | 2013 | 40 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2024 | 522 | 0.180 |
Why?
|
| Sodium Chloride | 1 | 2002 | 65 | 0.180 |
Why?
|
| Ligation | 3 | 2013 | 37 | 0.180 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.180 |
Why?
|
| Optical Fibers | 1 | 2021 | 11 | 0.180 |
Why?
|
| Clinical Trials as Topic | 3 | 2025 | 460 | 0.180 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 57 | 0.180 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 96 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 797 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 1655 | 0.180 |
Why?
|
| Curriculum | 5 | 2017 | 604 | 0.170 |
Why?
|
| Watchful Waiting | 1 | 2021 | 32 | 0.170 |
Why?
|
| Double-Blind Method | 4 | 2016 | 734 | 0.170 |
Why?
|
| Health Status Indicators | 2 | 2012 | 94 | 0.170 |
Why?
|
| Paraparesis | 1 | 2021 | 9 | 0.170 |
Why?
|
| Walking | 1 | 2023 | 242 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2016 | 718 | 0.170 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 157 | 0.160 |
Why?
|
| Health Facilities | 1 | 2020 | 44 | 0.160 |
Why?
|
| Sexism | 1 | 2020 | 33 | 0.160 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 55 | 0.160 |
Why?
|
| Cultural Competency | 1 | 2020 | 58 | 0.160 |
Why?
|
| Physicians, Women | 1 | 2020 | 41 | 0.160 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 76 | 0.160 |
Why?
|
| Intraoperative Care | 1 | 2020 | 38 | 0.160 |
Why?
|
| Hypertension | 2 | 2017 | 606 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 49 | 0.160 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2000 | 2 | 0.160 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 18 | 0.160 |
Why?
|
| Ultrasonography | 4 | 2014 | 489 | 0.160 |
Why?
|
| Cultural Diversity | 1 | 2020 | 54 | 0.160 |
Why?
|
| Vena Cava Filters | 1 | 2000 | 23 | 0.160 |
Why?
|
| Veins | 3 | 2013 | 63 | 0.160 |
Why?
|
| Quality of Life | 4 | 2023 | 1254 | 0.160 |
Why?
|
| Health Care Surveys | 4 | 2020 | 288 | 0.150 |
Why?
|
| Pancreatic Elastase | 2 | 2016 | 32 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2000 | 38 | 0.150 |
Why?
|
| Surveys and Questionnaires | 5 | 2019 | 2751 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 117 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2021 | 147 | 0.150 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 73 | 0.150 |
Why?
|
| Racism | 1 | 2020 | 92 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2014 | 147 | 0.150 |
Why?
|
| Emergencies | 2 | 2021 | 122 | 0.150 |
Why?
|
| Observer Variation | 1 | 2019 | 216 | 0.150 |
Why?
|
| Postoperative Care | 2 | 2016 | 125 | 0.140 |
Why?
|
| Hospitals, Teaching | 2 | 2017 | 105 | 0.140 |
Why?
|
| Atherectomy | 1 | 2018 | 8 | 0.140 |
Why?
|
| Body Weight | 1 | 2020 | 374 | 0.140 |
Why?
|
| General Surgery | 1 | 2021 | 211 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 106 | 0.140 |
Why?
|
| Pandemics | 2 | 2020 | 671 | 0.140 |
Why?
|
| Health Status | 2 | 2018 | 447 | 0.140 |
Why?
|
| Patient Education as Topic | 3 | 2016 | 481 | 0.140 |
Why?
|
| Reimbursement Mechanisms | 1 | 2018 | 41 | 0.140 |
Why?
|
| Coronary Vasospasm | 1 | 2017 | 11 | 0.130 |
Why?
|
| Graft Survival | 2 | 2009 | 296 | 0.130 |
Why?
|
| Preoperative Period | 2 | 2015 | 67 | 0.130 |
Why?
|
| Morbidity | 1 | 2017 | 110 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2017 | 43 | 0.130 |
Why?
|
| Competitive Bidding | 1 | 2017 | 4 | 0.130 |
Why?
|
| Hospital Charges | 1 | 2017 | 22 | 0.130 |
Why?
|
| Centralized Hospital Services | 1 | 2017 | 5 | 0.130 |
Why?
|
| Regional Health Planning | 1 | 2017 | 10 | 0.130 |
Why?
|
| ROC Curve | 4 | 2016 | 292 | 0.130 |
Why?
|
| Postoperative Period | 2 | 2014 | 130 | 0.130 |
Why?
|
| Foot | 1 | 2017 | 42 | 0.130 |
Why?
|
| Physicians | 1 | 2022 | 473 | 0.130 |
Why?
|
| Lost to Follow-Up | 1 | 2016 | 7 | 0.130 |
Why?
|
| Linear Models | 3 | 2016 | 404 | 0.130 |
Why?
|
| Self-Assessment | 1 | 2017 | 59 | 0.130 |
Why?
|
| Propensity Score | 4 | 2026 | 189 | 0.130 |
Why?
|
| Erythrocyte Transfusion | 1 | 2017 | 78 | 0.120 |
Why?
|
| Age Factors | 4 | 2021 | 1568 | 0.120 |
Why?
|
| Inservice Training | 1 | 2017 | 85 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 92 | 0.120 |
Why?
|
| Patient Admission | 1 | 2018 | 197 | 0.120 |
Why?
|
| Prevalence | 4 | 2024 | 1431 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2015 | 186 | 0.120 |
Why?
|
| Radial Artery | 1 | 2016 | 55 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 3 | 2008 | 196 | 0.120 |
Why?
|
| Oligonucleotides | 2 | 2008 | 229 | 0.120 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2016 | 67 | 0.120 |
Why?
|
| Axillary Artery | 1 | 2015 | 7 | 0.120 |
Why?
|
| Health Expenditures | 1 | 2017 | 121 | 0.120 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 432 | 0.120 |
Why?
|
| Embolism | 1 | 2016 | 41 | 0.120 |
Why?
|
| Breast Neoplasms, Male | 1 | 2015 | 14 | 0.120 |
Why?
|
| Remission Induction | 1 | 2015 | 148 | 0.120 |
Why?
|
| Vascular System Injuries | 1 | 2015 | 22 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2024 | 1008 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2015 | 66 | 0.110 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 36 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 363 | 0.110 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 82 | 0.110 |
Why?
|
| Organizational Objectives | 1 | 2015 | 59 | 0.110 |
Why?
|
| Anastomosis, Surgical | 2 | 2012 | 118 | 0.110 |
Why?
|
| Models, Organizational | 1 | 2015 | 91 | 0.110 |
Why?
|
| Economics, Hospital | 1 | 2014 | 15 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 256 | 0.110 |
Why?
|
| Focus Groups | 1 | 2015 | 319 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 105 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 303 | 0.100 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 246 | 0.100 |
Why?
|
| Career Choice | 1 | 2015 | 126 | 0.100 |
Why?
|
| Foot Ulcer | 1 | 2013 | 2 | 0.100 |
Why?
|
| Models, Biological | 1 | 2019 | 1192 | 0.100 |
Why?
|
| Inpatients | 2 | 2014 | 313 | 0.100 |
Why?
|
| Program Development | 1 | 2015 | 208 | 0.100 |
Why?
|
| Prosthesis Fitting | 1 | 2013 | 7 | 0.100 |
Why?
|
| Artificial Limbs | 1 | 2013 | 6 | 0.100 |
Why?
|
| Polytetrafluoroethylene | 1 | 2013 | 17 | 0.100 |
Why?
|
| Myocardial Revascularization | 1 | 2014 | 78 | 0.100 |
Why?
|
| Carotid Artery, Common | 1 | 2013 | 30 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2015 | 527 | 0.100 |
Why?
|
| Educational Measurement | 2 | 2017 | 213 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 229 | 0.100 |
Why?
|
| Administration, Intravesical | 1 | 2012 | 14 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 124 | 0.090 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 36 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 176 | 0.090 |
Why?
|
| Kidney | 1 | 2014 | 450 | 0.090 |
Why?
|
| Probability | 2 | 2009 | 168 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2013 | 200 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 213 | 0.090 |
Why?
|
| Ticlopidine | 1 | 2011 | 47 | 0.080 |
Why?
|
| Pneumonia | 1 | 2014 | 291 | 0.080 |
Why?
|
| Smoking | 4 | 2017 | 859 | 0.080 |
Why?
|
| Vasodilation | 1 | 2010 | 36 | 0.080 |
Why?
|
| Heart Failure | 3 | 2014 | 949 | 0.080 |
Why?
|
| Sex Factors | 3 | 2021 | 986 | 0.080 |
Why?
|
| Goals | 1 | 2011 | 96 | 0.080 |
Why?
|
| Heparin Antagonists | 1 | 2010 | 1 | 0.080 |
Why?
|
| Recurrence | 2 | 2013 | 654 | 0.080 |
Why?
|
| Protamines | 1 | 2010 | 6 | 0.080 |
Why?
|
| Dialysis | 1 | 2009 | 8 | 0.080 |
Why?
|
| Health Resources | 1 | 2010 | 92 | 0.080 |
Why?
|
| Asymptomatic Diseases | 3 | 2015 | 52 | 0.080 |
Why?
|
| Hematocrit | 1 | 2009 | 32 | 0.080 |
Why?
|
| Inguinal Canal | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cardiology Service, Hospital | 1 | 2009 | 17 | 0.080 |
Why?
|
| Accreditation | 1 | 2009 | 76 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1213 | 0.080 |
Why?
|
| Florida | 1 | 2009 | 46 | 0.070 |
Why?
|
| Peer Review, Research | 1 | 2009 | 46 | 0.070 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2008 | 1 | 0.070 |
Why?
|
| New York | 1 | 2009 | 144 | 0.070 |
Why?
|
| Cost Savings | 1 | 2009 | 58 | 0.070 |
Why?
|
| Congresses as Topic | 2 | 2019 | 76 | 0.070 |
Why?
|
| Education, Medical | 2 | 2020 | 182 | 0.070 |
Why?
|
| Aspirin | 2 | 2024 | 171 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2010 | 222 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2024 | 460 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2009 | 230 | 0.070 |
Why?
|
| Life Tables | 1 | 2007 | 23 | 0.070 |
Why?
|
| Intraoperative Period | 1 | 2007 | 34 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 27 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 152 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2008 | 309 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2008 | 251 | 0.060 |
Why?
|
| Constriction, Pathologic | 3 | 2014 | 130 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 106 | 0.060 |
Why?
|
| Fingers | 1 | 2006 | 48 | 0.060 |
Why?
|
| Boston | 1 | 2007 | 257 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 703 | 0.060 |
Why?
|
| Cost of Illness | 2 | 2019 | 170 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 371 | 0.060 |
Why?
|
| Consensus | 2 | 2017 | 181 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 322 | 0.060 |
Why?
|
| Algorithms | 1 | 2011 | 1038 | 0.060 |
Why?
|
| Educational Status | 2 | 2017 | 276 | 0.060 |
Why?
|
| Learning Curve | 2 | 2017 | 33 | 0.060 |
Why?
|
| Intention to Treat Analysis | 1 | 2024 | 21 | 0.060 |
Why?
|
| Task Performance and Analysis | 2 | 2017 | 128 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2025 | 156 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2025 | 139 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1159 | 0.050 |
Why?
|
| Motivation | 2 | 2016 | 293 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1123 | 0.050 |
Why?
|
| Guanine | 1 | 2023 | 26 | 0.050 |
Why?
|
| Organophosphorus Compounds | 1 | 2023 | 33 | 0.050 |
Why?
|
| Acute Disease | 2 | 2016 | 663 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2022 | 43 | 0.050 |
Why?
|
| Diffusion | 1 | 2002 | 82 | 0.050 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 427 | 0.050 |
Why?
|
| Catheterization | 1 | 2022 | 111 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 491 | 0.040 |
Why?
|
| Inflammation | 1 | 2008 | 1184 | 0.040 |
Why?
|
| Blood Transfusion | 2 | 2013 | 164 | 0.040 |
Why?
|
| Operative Time | 1 | 2021 | 92 | 0.040 |
Why?
|
| Renal Artery Obstruction | 1 | 2020 | 18 | 0.040 |
Why?
|
| Job Description | 1 | 2020 | 24 | 0.040 |
Why?
|
| Lipids | 1 | 2023 | 327 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2023 | 2604 | 0.040 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2020 | 8 | 0.040 |
Why?
|
| Career Mobility | 1 | 2020 | 63 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 858 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 57 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2000 | 24 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2021 | 495 | 0.040 |
Why?
|
| Stainless Steel | 1 | 2000 | 14 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2000 | 74 | 0.040 |
Why?
|
| Neck Pain | 1 | 2000 | 21 | 0.040 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2020 | 17 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2000 | 100 | 0.040 |
Why?
|
| Specialization | 1 | 2020 | 82 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2020 | 115 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 152 | 0.040 |
Why?
|
| Fertilization in Vitro | 1 | 2000 | 83 | 0.040 |
Why?
|
| Global Burden of Disease | 1 | 2019 | 13 | 0.040 |
Why?
|
| Workplace | 1 | 2020 | 179 | 0.040 |
Why?
|
| International Cooperation | 1 | 2019 | 87 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 109 | 0.040 |
Why?
|
| Equipment Design | 1 | 2000 | 360 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 278 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2017 | 13 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 178 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2000 | 196 | 0.030 |
Why?
|
| Hotlines | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cadaver | 1 | 2017 | 127 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2000 | 418 | 0.030 |
Why?
|
| Embolectomy | 1 | 2016 | 15 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 136 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2016 | 66 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 149 | 0.030 |
Why?
|
| Awareness | 1 | 2016 | 73 | 0.030 |
Why?
|
| Shock | 1 | 2016 | 33 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 30 | 0.030 |
Why?
|
| Protective Factors | 1 | 2015 | 33 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 297 | 0.030 |
Why?
|
| Smartphone | 1 | 2016 | 73 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 159 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2015 | 65 | 0.030 |
Why?
|
| Angiography | 1 | 2015 | 154 | 0.030 |
Why?
|
| Comprehension | 1 | 2016 | 138 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 458 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2014 | 49 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2016 | 140 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2014 | 30 | 0.030 |
Why?
|
| Diabetic Foot | 1 | 2013 | 11 | 0.030 |
Why?
|
| Compression Bandages | 1 | 2013 | 2 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2016 | 253 | 0.030 |
Why?
|
| Early Ambulation | 1 | 2013 | 10 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2013 | 16 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 4772 | 0.030 |
Why?
|
| Child | 1 | 2023 | 4554 | 0.020 |
Why?
|
| Troponin | 1 | 2013 | 39 | 0.020 |
Why?
|
| Motor Skills | 1 | 2013 | 61 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2690 | 0.020 |
Why?
|
| Health Services Research | 1 | 2014 | 265 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 20 | 0.020 |
Why?
|
| Pregnancy | 1 | 2000 | 2362 | 0.020 |
Why?
|
| Checklist | 1 | 2013 | 69 | 0.020 |
Why?
|
| Video Recording | 1 | 2013 | 139 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 292 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2012 | 62 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 554 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 853 | 0.020 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 132 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 710 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1469 | 0.020 |
Why?
|
| Communication | 1 | 2016 | 595 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 294 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 601 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2010 | 80 | 0.020 |
Why?
|
| Back Pain | 1 | 2010 | 49 | 0.020 |
Why?
|
| Home Care Services | 1 | 2010 | 97 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2010 | 102 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2009 | 106 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 161 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 291 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 235 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 114 | 0.020 |
Why?
|
| Cause of Death | 1 | 2008 | 221 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 166 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 129 | 0.020 |
Why?
|
| Creatinine | 1 | 2007 | 135 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 250 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2007 | 120 | 0.020 |
Why?
|
| Forearm | 1 | 2005 | 22 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2005 | 37 | 0.010 |
Why?
|
| Time | 1 | 2004 | 29 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 59 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 67 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2004 | 179 | 0.010 |
Why?
|
| Anesthesia | 1 | 2001 | 52 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2000 | 195 | 0.010 |
Why?
|
| Medical Errors | 1 | 2001 | 198 | 0.010 |
Why?
|